| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-12 |
4 |
S |
$13.67 |
$651,690 |
D/D |
(47,382) |
2,844,893 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2008-11-19 |
4 |
D |
$59.24 |
$1,383,669 |
D/D |
(23,357) |
2,850,589 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2008-11-19 |
4 |
OE |
$11.25 |
$1,383,561 |
D/D |
83,728 |
2,854,489 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-10-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,886,590 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-02 |
4 |
B |
$9.48 |
$40,764 |
D/D |
4,300 |
2,890,890 |
2.37 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-12 |
4 |
S |
$13.70 |
$650,038 |
D/D |
(47,287) |
2,892,275 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-12 |
4 |
S |
$13.77 |
$456,498 |
D/D |
(33,134) |
2,939,562 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
166,000 |
2,972,696 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-04 |
4 |
B |
$9.04 |
$1,808,260 |
D/D |
200,000 |
3,090,890 |
2.45 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2019-05-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,661 |
3,101,149 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • • |
2020-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,100 |
3,103,249 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2012-01-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,124,876 |
|
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2017-02-13 |
4 |
B |
$1.40 |
$1,363,713 |
I/I |
974,081 |
3,132,220 |
2.64 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-02-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,137,058 |
|
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-01-11 |
4 |
A |
$13.15 |
$6,246,250 |
D/D |
475,000 |
3,142,288 |
0 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-05-03 |
4 |
B |
$13.01 |
$59,746 |
D/D |
4,591 |
3,146,879 |
2.39 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-05-05 |
4 |
B |
$13.66 |
$5,585 |
D/D |
409 |
3,147,288 |
2.39 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-08-05 |
4 |
B |
$14.07 |
$293,639 |
D/D |
20,865 |
3,168,153 |
2.39 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2009-11-05 |
4 |
B |
$4.50 |
$525,000 |
D/D |
110,000 |
3,200,890 |
2.45 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2011-08-08 |
4 |
B |
$14.00 |
$1,107,494 |
D/D |
79,135 |
3,247,288 |
2.39 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-19 |
4 |
B |
$16.60 |
$165,954 |
D/D |
10,000 |
3,255,650 |
2.39 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2017-12-19 |
4 |
B |
$2.26 |
$4,309,241 |
I/I |
1,906,744 |
3,270,481 |
1.5 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-20 |
4 |
B |
$16.48 |
$260,577 |
D/D |
15,815 |
3,271,465 |
2.39 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-03-21 |
4 |
B |
$16.65 |
$665,928 |
D/D |
40,000 |
3,311,465 |
2.39 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2012-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
3,315,053 |
0 |
- |
|
634 Records found
|
|
Page 15 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
